Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.
Laurent KodjikianLluís Arias BarquetAndrás PappPeter J KertesEdoardo MidenaJan ErnestRufino SilvaThomas SchmelterTobias NiesenSergio LealPublished in: Advances in therapy (2024)
ClinicalTrials.gov Identifier: NCT02540954.